Gender, Race Affects Access to SGLT2-Inhibitor Therapy for T2DM
Women, Black or Asian patients less likely to receive sodium-glucose cotransporter 2 inhibitor treatment for type 2 diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.